IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2006;47:213-221.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.05-0334
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fautsch, M. P.
Right arrow Articles by Johnson, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fautsch, M. P.
Right arrow Articles by Johnson, D. H.

Perfusion of His-Tagged Eukaryotic Myocilin Increases Outflow Resistance in Human Anterior Segments in the Presence of Aqueous Humor

Michael P. Fautsch,1 Cindy K. Bahler,1 Anne M. Vrabel,1 Kyle G. Howell,1 Nils Loewen,2 Wulin L. Teo,2 Eric M. Poeschla,2 and Douglas H. Johnson1

1From the Department of Ophthalmology and the 2Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, Minnesota.

PURPOSE. A previous study by the authors has shown that recombinant myocilin purified from a prokaryotic expression system increases outflow resistance in cultured human anterior segments. The present study was performed to determine whether full-length myocilin purified from a human trabecular meshwork cell expression system alters outflow resistance after infusion into human anterior segments.

METHODS. A feline immunodeficiency virus vector encoding both full-length myocilin (amino acids 1-503 fused to C-terminal V5 and six-histidine epitopes) and puromycin resistance was used to transduce a transformed trabecular meshwork cell line (TM5). Stably expressing cells were selected with puromycin. Recombinant myocilin was purified from the media using nickel ion affinity chromatography. Control purifications were performed on media from parental TM5 cells. Anterior segments of human eyes were placed in organ culture and perfused with either Dulbecco’s modified Eagle’s medium (DMEM) or DMEM supplemented with 50% porcine aqueous humor. One eye received an anterior chamber exchange with recombinant myocilin (2 µg/mL), whereas the fellow eye received an equal volume of control. Immunohistochemistry was performed with anti-myocilin and anti-V5 antibodies. Native polyacrylamide gel electrophoresis was used to analyze myocilin complex formation in porcine aqueous humor.

RESULTS. Recombinant myocilin in porcine aqueous humor increased outflow resistance in cultured human anterior segments (91% ± 68% [mean ± SD] versus 18% ± 31% in fellow control eye; n = 9, P = 0.004). Maximum outflow resistance was obtained 5 to 17 hours after infusion and remained above baseline for >3 days. Recombinant myocilin also increased outflow resistance in eyes incubated in DMEM, but only if myocilin was preincubated with porcine aqueous humor (78% ± 77% when preincubated in DMEM containing porcine aqueous humor versus 13% ± 15% when preincubated with DMEM alone, n = 6, P = 0.03). Recombinant myocilin appears to form a complex in porcine aqueous humor with a heat-labile protein(s). Immunohistochemistry revealed the presence of myocilin in the juxtacanalicular region of the trabecular meshwork.

CONCLUSIONS. Myocilin purified from human trabecular meshwork cells increased outflow resistance in cultured human anterior segments, but only after incubation with porcine aqueous humor. Recombinant myocilin appears to form a complex in porcine aqueous humor that enables it to bind specifically within the trabecular meshwork.




This article has been cited by other articles:


Home page
 IOVSHome page
J.-D. Aroca-Aguilar, F. Martinez-Redondo, F. Sanchez-Sanchez, M. Coca-Prados, and J. Escribano
Functional Role of Proteolytic Processing of Recombinant Myocilin in Self-Aggregation
Invest. Ophthalmol. Vis. Sci., January 1, 2010; 51(1): 72 - 78.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. A. Pfeffer, C. A. DeWitt, M. Salvador-Silva, M. E. Cavet, F. J. Lopez, and K. W. Ward
Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids
Invest. Ophthalmol. Vis. Sci., January 1, 2010; 51(1): 437 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Koga, X. Shen, J.-S. Park, Y. Qiu, B.-C. Park, R. Shyam, and B. Y.J.T. Yue
Differential Effects of Myocilin and Optineurin, Two Glaucoma Genes, on Neurite Outgrowth
Am. J. Pathol., January 1, 2010; 176(1): 343 - 352.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. V. Patel, L. A. Bachman, C. R. Hann, C. K. Bahler, and M. P. Fautsch
Human Corneal Endothelial Cell Transplantation in a Human Ex Vivo Model
Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2123 - 2131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Sanchez-Sanchez, F. Martinez-Redondo, J. D. Aroca-Aguilar, M. Coca-Prados, and J. Escribano
Characterization of the Intracellular Proteolytic Cleavage of Myocilin and Identification of Calpain II as a Myocilin-processing Protease
J. Biol. Chem., September 21, 2007; 282(38): 27810 - 27824.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology